Cluster of Excellence Precision Medicine in Chronic Inflammation (PMI)

About the Cluster

More and more people in industrial nations are suffering from chronic inflammatory diseases such as Crohn’s disease, psoriasis, diabetes and rheumatism. In the Cluster of Excellence “Precision Medicine in Chronic Inflammation” (PMI), scientists from various medical disciplines and fundamental research are working together on an interdisciplinary basis to significantly improve the diagnosis, treatment and prevention of these diseases. Their vision is to achieve complete control over the diseases – at every stage and as early as possible.

More about the Cluster of Excellence Precision Medicine in Chromic Inflammation (PMI)

Why precision medicine?

Preview

Please note: Once you watch the video, data will be transmitted to Youtube/Google. For more information, see Google Privacy.

Cluster news

Microscopic image bacterium

Evolutionary trade-offs: Balancing genetic disease risks and pathogen protection

Novel way to identify previously unknown pathogens via disease genes

 

 
[EN]

Review: COVID-19 host genetics and ABO blood group susceptibility

What is the role of ABO blood group in SARS-CoV-2 infection and/or severe COVID-19, and what genetic risk factors are known to date?

 

Two PMI researchers rank among the world's top female scientists

Prof. Christine Klein and Prof. Jeanette Erdmann are among the top 1000 in the "Best Female Scientist" ranking of the Research.com.

 

Six PMI Clustermembers are "Highly Cited Researcher" 2022

Among the most cited researchers worldwide in 2022 are six members of the Cluster of Excellence "Precision Medicine in Chronic Inflammation".